SC
TAK icon

Savant Capital’s Takeda Pharmaceutical TAK Stock Holding History

Savant Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$962K Buy
56,536
+29,082
+106% +$481K ﹤0.01% 903
2026
Q1 		$508K Buy
27,454
+6,474
+31% +$114K ﹤0.01% 901
2025
Q4 		$327K Sell
20,980
-1,227
-6% -$17.5K ﹤0.01% 1012
2025
Q3 		$325K Sell
22,207
-4,056
-15% -$60.2K ﹤0.01% 988
2025
Q2 		$406K Buy
+26,263
New +$388K ﹤0.01% 830
2023
Q4 		– Sell
-10,707
Closed -$166K – 872
2023
Q3 		$166K Sell
10,707
-343
-3% -$5.31K ﹤0.01% 770
2023
Q2 		$174K Buy
+11,050
New +$181K ﹤0.01% 752

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Savant Capital's TAK Position: Q2 2026 in Review

Savant Capital increased its Takeda Pharmaceutical (TAK) stake by 106% in Q2 2026, buying an estimated $481K and bringing the position to 56,536 shares worth $962K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Savant Capital first reported a position in TAK in Q2 2023 and has held it in 7 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Savant Capital held 56,536 shares of Takeda Pharmaceutical worth $962K as of Q2 2026.
  • Savant Capital bought 29,082 Takeda Pharmaceutical shares in Q2 2026, an estimated $481K.
  • Takeda Pharmaceutical made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #903 holding.
  • Savant Capital first reported a position in Takeda Pharmaceutical in Q2 2023 and has held it in 7 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.